In summary, we used WES to further characterize genetic differences between persistent and resolved sarcoidosis patients and to test the hypothesis whether different variations are associated in relation to the class II markers (HLA-DRB1*03:01/HLA-DRB1*04:01-DPB1*04:01). The gene discussed is HLA-DRB1; the disease is sarcoidosis.